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Abstract
A multi-site, steady-state Fo¨rster resonance energy transfer (FRET) approach was used to quantify Ca2+-induced changes in
proximity between donor loci on human cardiac troponin I (cTnI), and acceptor loci on human cardiac tropomyosin (cTm)
and F-actin within functional thin filaments. A fluorescent donor probe was introduced to unique and key cysteine residues
on the C- and N-termini of cTnI. A FRET acceptor probe was introduced to one of three sites located on the inner or outer
domain of F-actin, namely Cys-374 and the phalloidin-binding site on F-actin, and Cys-190 of cTm. Unlike earlier FRET
analyses of protein dynamics within the thin filament, this study considered the effects of non-random distribution of
dipoles for the donor and acceptor probes. The major conclusion drawn from this study is that Ca2+ and myosin S1-binding
to the thin filament results in movement of the C-terminal domain of cTnI from the outer domain of F-actin towards the
inner domain, which is associated with the myosin-binding. A hinge-linkage model is used to best-describe the finding of a
Ca2+-induced movement of the C-terminus of cTnI with a stationary N-terminus. This dynamic model of the activation of the
thin filament is discussed in the context of other structural and biochemical studies on normal and mutant cTnI found in
hypertrophic cardiomyopathies.
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Introduction
The Ca2+-tropinin complex acts as a molecular-switch in the
regulation of cardiac muscle contraction. Cardiac thin filaments
are composed of polymerized actin protomers decorated with
stoichiometric levels of the tropomyosin dimer (cTm) and the
troponin complex (cTn), in the ratio of 7:1:1 respectively. cTn is
composed of three subunits: troponin C (TnC), troponin I (TnI)
and troponin T (TnT) [1]. TnC, which serves as the Ca2+-
receptor, has two globular sub-domains linked by an extended a-
helix [2,3]. TnI interacts with F-actin, TnC, TnT and tropomy-
osin (cTm). TnI inhibits the actomyosin ATPase in the thin
filament although inhibition is reversed upon Ca2+-binding to the
TnC complex [4]. High-resolution structural analyses have shown
that the two EF-hand motifs on the N-lobe of skeletal TnC open
up upon Ca2+-binding [5–8] leading to the unfolding of a short a-
helix within the TnI inhibitory segment [9]. This conformational
change allows TnI to bind more tightly to TnC [10,11] and, as a
result, the interaction between TnI and F-actin weakens. This
latter change is key to the activation of the thin filament, as it
should allow myosin to form a strong bond with F-actin [12,13].
Collectively, these studies suggest that the activation of the thin
filament requires significant, Ca2+-triggered, concerted structural
dynamics [14].
Understanding the role of protein structural dynamics in Ca2+-
regulation of muscle contraction might help to explain how
specific single point mutations in thin filament proteins lead to
hypertrophic and dilated cardiomyopathies (HCM and DCM).
For example, many of the HCM mutations in TnC and TnI that
lead to reduced cardiac output are single point and conservative
[15–19], and on the face of it, unlikely to alter the overall structure
or interactions of the mutated protein within the thin filament. We
are testing the hypothesis that the deleterious effects of these
mutations are a result of altered structural dynamics, for example
one that might change the rate of a conformational transition or
coupling to a neighboring subunit in the filament. Ideally one
would test this hypothesis by carrying out high-resolution
structural analyses of individual Tn subunits within functional
thin filaments at different states of the crossbridge cycle. Cryo-
electron microscopy of reconstituted or intact muscle fibers is the
most informative of these techniques although the information is
carried out on fixed samples. On the other hand, Fo¨rster
resonance energy transfer (FRET) provides sensitive and dynamic
information on changes in proximity between specific loci on
multiple labeled proteins within functional thin filament under
physiological conditions of temperature and ionic composition.
The FRET-approach has been applied in the characterization of
proximity relationships within or between Tn subunits and their
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complexes with F-actin. Some of these studies indicate that Ca2+-
binding to TnC brings about a change of conformation in the
region of the TnI-TnC interface [20–24]. For example, in fast-
skeletal (fs) TnI, Cys-133 is thought to move away from sites on
actin including Gln-41, Lys-61, Cys-374 and the bound nucleo-
tide, while a far smaller change is found at the N-terminus of
skTnI (Cys-9). These studies indicate that the Ca2+-triggered
activation of the thin filament may proceed in part via a hinge-like
bending motion of TnI, in which the C-terminal domain of TnI
moves away from the outer domain of actin filament while the N-
terminal domain of TnI remains fixed [25,26]. Farah, et al. [27]
also showed that the C-terminal region of fsTnI (at least from
residue 103 to 156) is involved in the Ca2+-dependent regulation of
the thin filament. Finally a recent kinetic study suggests that
structural transitions are involved during two steps of Ca2+-
activation of the thin filament – these include the rapid
dissociation of the C-terminal (mobile) domain of TnI from the
actin filament, associated with Ca2+-binding, and a slower
switching of the inhibitory region on TnI that is implicated in
inhibiting the formation of strongly bound cross-bridges [28].
These earlier studies have for the most part been carried out on
thin filament preparations derived from skeletal muscle. Now
while the component proteins of cardiac thin filaments are
homologous to those in skeletal muscle, there are some significant
differences in their structure and mode of regulation. For example,
cTnI has 31 additional residues at the N-terminus and phosphor-
ylation within this region decreases the Ca2+ sensitivity of the
cardiac thin filament [29,30]. Moreover, earlier FRET-based
analysis of Ca2+-mediated changes in proximity between sites on
TnI and F-actin have been limited to labeling sites on the outer
domain of F-actin (Figure 1). Moreover, the analysis of FRET
efficiency in these studies were based on random distributions of
dipole moments for the donor and acceptor probes, which is not
valid when one or both probes are immobile during the excited
state lifetime [14,31].
We improved and extended these earlier FRET studies in an
investigation of the nature of conformational transitions within
human cTnI during Ca2+-activation of contraction within fully
functional, recostituted thin filaments. The multi-site FRET
analysis includes probing proximity changes in response to Ca2+-
and myosin II binding to thin filaments and an evaluation of the
effect of the orientation of donor and acceptor dipole moments on
calculated changes in proximity [14]. The donor sites on cTnI
were chosen to minimize any structral perturbation associated
with their labelling, and included residues 150–186 of cTnI, which
inhibits actomyosin ATPase [27] and is known to move away from
Cys-374 of F-actin. The acceptor sites were selected to probe
motions of cTnO with respect to the outer and inner domains of F-
actin as well as cTm.
Materials and Methods
Cardiac tropomyosin and troponin I
The cDNA of human cardiac tropomyosin and troponin I were
isolated by PCR from an adult human heart cDNA library
(Invitrogen) with the following primers:
For cTm: GCGGGATCCATGGACGCCATCAAGAAGAA-
GATG (Forward),
GCGAAGCTTTTATATGGAAGTCATATCGTTGAGAG
(Reverse)
For cTnI: GCGGGATCCATGGCGGATGGGAGCAGCG
(Forward),
GCGAAGCTTTCAGCTCTCAAACTTTTTCTTGC (Re-
verse),
The endogenous cysteine residues in wild type cTnI (Cys80 and
Cys 97) were substituted with serine. Other substitutions in cTnI
were made at V107C, A151C, V188C, A197C and S210C to
generate five single cysteine mutants. The genes of cTnI mutants
and cTm were cloned into vector pQE-30(Qiagen, CA) between
BamH I and Hind III sites. The proteins were expressed in
M15pRep4 E. coli strain and purified by running through Ni-
NTA column (Qiagen, CA) in the presence of 6 M urea.
Other protein preparation
Chicken skeletal G-actin was prepared from acetone powder
using the standard polymerization/depolymerization protocol as
described by Heidecker et al [32]. Bovine cTnT and cTnC are
prepared according to Potter [33]. Rabbit skeletal myosin S1 was
prepared according to Weeds & Taylor [34].
Labeling of proteins
Cysteine residues in G-actin and cTm were labeled in the
presence of a 5-fold excess of TMR-5-maleimide (Invitrogen) while
cTnI mutants were labeled using a 5-fold excess of fluorescein-5-
maleimide (Anaspec) in DTT-free G-buffer (5 mM Tris, 0.2 mM
CaCl2, 0.1 mM ATP, pH 8.0), Tm buffer (50 mM Tris, 500 mM
KCl, pH8.0), or urea buffer (50 mM Tris, 500 mM KCl, 6 M
urea, pH8.0) respectively at 37uC for 2 hours. Unlabeled dye was
removed by running the reaction mixture through an Econo-Pac
10DG column (Bio-Rad) for G-actin and cTm or a Ni-NTA
column for cTnI. SDS-PAGE was used to confirm all of the dye
was covalently bound to the protein. The final concentration of the
fluorescence label on the protein was determined from measure-
ments of their absorption spectra recorded on a Shimadzu
PC1601 spectrophotometer. The corresponding concentration of
Figure 1. A cross section of the thin filament based on an actin
filament model by Oda et al. [45]. The acceptor labeling sties used
in previous FRET studies (Gln41, Lys61, Cys374 and the bound
nucleotide) are shown as red balls, and are located in the outer
domain of actin filament. In this study, acceptors are labeled on
phalloidin (shown as a blue ball on the inner domain of actin filament),
Cys374 on actin, or Cys190 on cTm. The donor probe labeled on cTnI is
shown as a green ball.
doi:10.1371/journal.pone.0050420.g001
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protein in the conjugate was measured by using the Bradford
protein assay kit (Bio-Rad). The labeling ratios were calculated by
dividing the concentration of the fluorescence probe by that of the
protein.
Other reagents
Prof. Heinz Faulstich, Max Planck Institute for Cell Biology
kindly provided IC3-Phalloidin for these studies.
Reconstitution of thin filaments
Each of the 5 single cysteine labeled cTnI mutants (Fluorescein-
cTnI) were mixed with purified bovine cardiac cTnT and cTnC at
a molar ratio of 1:1:1 in urea buffer and dialyzed against buffers
containing 6 M, 4 M, 3 M, 2 M, 1 M and 0 M urea in order to
reconstitute the functional cTn complex. Superose 6 chromatog-
raphy was used to purify labeled cTn complexes. TMR-labeled
and unlabeled G-actin were polymerized overnight at 4C in the
presence of a 1.5-fold excess of IC3-phalloidin or unlabeled
phalloidin in F-buffer (0.2 mM CaCl2, 0.1 mM ATP, 1 mM
DTT, 100 mM KCl, 2 mM MgCl2 and 5 mM Tris, pH 8.0). The
F-actin complex was purified by centrifugation at 85,0006g for an
hour and by resuspending the pellet in F-buffer. Thin filaments
were reconstituted with F-actin, cTm and cTn with a molar ratio
of 7:1:1. The mixture was left on ice overnight to allow for
complex formation and then centrifuged at 85,0006g for an hour.
The pellet was resuspended in ATPase assay buffer (10 mM
MOPS, 3 mM MgCl2 and 1 mM ATP, pH 7.0, with 0.1 mM
CaCl2 or 1 mM EGTA) for the ATPase assays, or in F-buffer for
fluorescence measurement.
ATPase activity assays
The malachite green phosphate assay was used to measure the
Ca2+-activated S1-ATPase activity in thin filaments [14,35].
Fluorescence spectra
Steady state emission spectra were measured at 25uC using an
SLM-AB2 fluorimeter, with excitation wavelength at 490 nm and
emission between 500,650 nm (both with 4 nm band pass). The
magic angle excitation was employed to eliminate polarization
errors from the instrument [36].
FRET based molecular proximity analysis
The efficiency of FRET between a unique donor and a unique
acceptor probe in the thin filament was calculated using the
relationship as detailed in Wang et al [14]:
ET~(1{
FDA
FD
)
1
fA
where FDA and FD are the quantum yields of the donor probe in
the presence and absence of the acceptor probes respectively and
fA is the fraction of acceptor labeling. The efficiency of FRET (ET)
is related to the distance between the donor probe (R) and the
acceptor probes according to:
Figure 2. The Ca2+-regulated S1 ATPase activities within thin
filaments reconstituted with wild-type cTn and cTn mutants
conjugates. Fluorescein labeled human cTnI single cysteine mutants
were reconstituted into cTn complex with bovine cTnC and cTnT as
described in the methods section. 0.71 mM wild-type bovine cTn or
reconstituted cTn was mixed with 0.71 mM human cTm and 5 mM
chicken skeletal actin filament to reconstitute thin filaments. 0.1 mM S1
was added to the thin filaments and their ATPase activities were
measured at 25uC in ATPase assay buffer (10 mM MOPS, 3 mM MgCl2
and 1 mM ATP, pH 7.0, with 0.1 mM CaCl2 or 1 mM EGTA). The ATPase
activities were measured by determining the free phosphate concen-
tration using the Malachite green method. The ATPase rates are shown
as columns (n = 3) for the wild-type cTn and cTn mutants conjugates
(i.e. cTn107C, cTn151C, cTn188C, cTn197C and cTn210C), in which the
color scheme is black for the thin filament in the presence of Ca2+ and
red without Ca2+.
doi:10.1371/journal.pone.0050420.g002
Table 1. Quantum yields of Fluorescein labeled troponin I single cysteine mutants and Forster distances between Fluorescein and
the acceptors in different conditions.
Quantum yields Foerster distances (nm)
Fluorescein-TMR Fluorescein-IC3
2S1 +S1 2S1 +S1 2S1 +S1
2Ca2+ +Ca2+ 2Ca2+ +Ca2+ 2Ca2+ +Ca2+ 2Ca2+ +Ca2+ 2Ca2+ +Ca2+ 2Ca2+ +Ca2+
TnI107 0.26 0.29 0.29 0.28 4.4 4.5 4.5 4.4 4.8 4.9 4.9 4.8
TnI151 0.30 0.32 0.34 0.35 4.5 4. 6 4.6 4.6 4.9 5.0 5.0 5.0
TnI188 0.31 0.35 0.36 0.38 4.5 4.6 4.6 4.7 4.9 5.0 5.1 5.1
TnI197 0.33 0.35 0.34 0.38 4.6 4.6 4.6 4.7 5.0 5.0 5.0 5.1
TnI210 0.32 0.32 0.32 0.32 4.5 4.6 4.5 4.6 5.0 5.0 5.0 5.0
doi:10.1371/journal.pone.0050420.t001
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ET~
R60
R60zR
6
where R0 is the Fo¨rster distance, which is given by Lakowicz [37]
R60~wDk
2 9000(ln10)
128p5Nn4
  ð?
0
FD(l)eA(l)l
4dl
For an assumed k2 value of 2/3, and with n being taken 1.33,
then by expressing F(l) in units of M21cm21(nm)4, the Fo¨rster
distance (in A˚) can be calculated by using:
R0~0:163(wDJ(l))
1=6
Where J(l) is the spectral overlap integral, which can be
calculated using the expression
J(l)~
Ð?
0
FD(l)e(l)l
4dlÐ?
0
FD(l)dl
Results
Design of FRET experiments in reconstituted cardiac thin
filaments
Farah and Reinach [27] showed that residues 120–156 of skTnI
(corresponding to residue 150–186 of cTnI) are essential for the
inhibitory function that skTnI exerts on the thin filament. In this
study five sites within this region of cTnI were selected for donor
labeling corresponding to residue numbers 107, 151, 188, 197 and
210,(see later figures of the thin filament structure). The fixed
acceptor sites included those on the outer and inner domains of F-
actin and at Cys-190 of cTm. All eight labeling sites were chosen
so as to minimize the impact of the probe molecule and in
replacing a wild-type residue with a cysteine residue. The donor
and acceptor sites employed in this study greatly expands the scope
of FRET-based determinations of proximity in relaxed and
activated thin filaments compared to earlier studies.
Labeling of cTnI with Fluorescein-5-maleimide
The labeling ratio of fluorescein to cTnI in the five cTnI
mutants was calculated by using absorption spectroscopy and the
Bradford assay to measure the concentrations of fluorescein and
cTnI respectively [32]. The calculated labeling ratio was close to
parity in each of the 5 conjugates: 0.83 for TnI 107C; 0.87 for TnI
151C; 0.83 for TnI 188C; 0.92 for TnI 197C; and 0.87 for TnI
210C.
The effect of introducing a fluorescein group into the cTnI on
the function and regulation of the reconstituted thin filament was
evaluated for each mutant by measuring the S1-ATPase in the
absence and presence of calcium. A thin filament preparation
reconstituted with unlabeled wild type bovine cTn was used as a
control sample for these studies (Figure 2). In most cases, the
reconstituted fluorescein-cTnI labeled thin filaments exhibited
rates of ATPase activity in the absence and presence of Ca2+-that
were similar to the respective rates with control thin filaments. In
the case of TnI107C, the activation by Ca2+ was somewhat
reduced.
FRET based analysis the cTnI mutants conjugates within
thin filaments
Having shown that cTnI conjugates of fluorescein can substitute
for unlabelled cTnI within functional, reconstituted thin filaments,
steady-state fluorescence emission spectra were recorded for each
thin filament preparation in the absence and presence of acceptor
probes. These studies allow for the calculation of the quantum
yield of the fluorescein-cTnI donor probe in each preparation, and
the efficiency of FRET. The quantum yield of the fluorescein in
each sample was determined according to:
wD~wR
F
FR
ODR
OD
n2
n2R
where WR is the fluorescence intensity of a dilute solution
(OD,0.1 at 480 nm) of fluorescein in 0.1 M NaOH, which has
a known quantum yield taken as 0.95 [37]. F and FR are the
integrated fluorescence emission intensities of fluorescein in the
thin filament preparation and in the reference solution respective-
ly; OD and ODR are the optical densities (absorption at 490 nm)
of fluorescein the thin filament preparation and in the reference
Table 2. Anisotropy of the donor and acceptor probes labeled in the thin filaments reconstituted with wild-type or single cysteine
mutants of cTnI.
Donor Acceptor
TnI107 TnI151 TnI188 TnI197 TnI210 IC3-ph actin374 Tm190
2Ca2+ 0.203 0.176 0.200 0.203 0.172 0.285 0.313 0.242
+Ca2+ 0.225 0.212 0.203 0.180 0.154 0.283 0.320 0.245
+Ca2+,+S1 0.216 0.226 0.190 0.186 0.157 0.293 0.313 0.281
doi:10.1371/journal.pone.0050420.t002
Table 3. Orientation of TMR labeled on cys-374 on actin to
skeletal TnI residues calculated from the thin filament model
(Pirani, et al., 2006), and its effect on Foster distance
calculation.
sTnI74(2Ca2+/+Ca2+) sTnI118(2Ca2+) sTnI118(+Ca2+)
cos2h 0.037 0.118 0.666
,k2. 0.370 0.451 0.999
R0/R0 (2/3) 0.91 0.94 1.07
doi:10.1371/journal.pone.0050420.t003
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solution respectively; n and nR are the refractive indices of the thin
filament preparation and the reference respectively, which are
taken as being identical at 1.33. Fluorescence spectral measure-
ments were conducted at 22uC using an excitation wavelength of
490 nm, while the emission intensity was integrated between
500 nm and 650 nm. The values of the relative quantum yields
were calculated as indicated and are summarized in Table 1.
FRET analysis and the problem of the orientation factor
The overlap integral between the absorption spectrum of the
acceptor probe and the emission spectrum of the donor probe,
J(l), was calculated according to Wang et al (2006) using a molar
extinction coefficient for Cy3 of 150,000 M21 cm21 (GE
Healthcare) and 95,000 M21 cm21 for TMR (Invitrogen). The
results of these calculations are: for the fluorescein-IC3 FRET pair
J(l) = 2.48861015 M21 cm21(nm)4 and for the fluorescein-TMR
FRET pair, J(l) = 1.47661015 M21 cm21(nm)4. The only un-
known parameter in the Fo¨rster equation is the orientation
factor,k2, which can be computed using the relationship:
k2~(m^D
:m^A{3(m^D
:m^R)(m^A
:m^R))
2
where m^D, m^A, m^R are the unit vectors of the donor dipole moment,
the acceptor dipole moment and the vector connecting the centers
of the donor and acceptor. One needs to know the coordinates of
the donor and acceptor dipoles in order to calculate the
orientation factor, and these are rarely available (but see Yan &
Marriott [38] for an experimental determination of k2). However,
if one can show that both probes undergo unrestricted, isotropic
motions during their excited state lifetime, then one is justified in
using an averaged orientation factor vk2w of 2/3 in the FRET
calculation. Orientational freedom is widely assumed and applied
to distance calculations using FRET often without any justification
e.g. by measuring the steady-state anisotropy values of the donor
and acceptor probes. Moreover, Vanbeek et al [31] have argued
that this assumption is not strictly valid in cases where the
orientation and the distance between the donor and acceptor
dipoles are correlated. On the other hand, Mun˜oz-Losa, et al [39].
found that the error introduced by using an ideal dipole
approximation decreased while the distance increased. The error
drops to ,10% for distances greater than 5 nm (i.e. .R0).
The k2 value can be estimated by using the Dale-Eisinger
approach [14,40,41], which assumes that one dipole is fixed while
the other one undergoes an isotropic motion i.e.,
vk2w~ 1
3
(1z3(m^A
:m^R)
2)~
1
3
(1z3 cos2h)
where h is the angle between the acceptor dipole moment and the
line connecting the centers of the donor and acceptor. The largest
error introduced by using this ideal dipole approximation should
not exceed 12% [14]. From Table 2, it can be seen that the steady-
state anisotropy values for the five fluorescein conjugates of cTnI,
in reconstituted thin filaments, were low (,0.2) compared to
values for the corresponding acceptor probes (.0.28). Thus the
assumption that the dipoles of the donor and acceptor probes
randomize during their excited state lifetimes is not justified. To
assess the effect of the limited distribution of acceptor dipole
Figure 3. Emission spectra of the thin filament reconstituted with Fluorescein labeled cTnI151C in the presence of unlabeled- and
IC3-labeled phalloidin. Fluorescein labeled cTnI151C was reconstituted into cTn with bovine cTnC and cTnT. 0.71 mM reconstituted cTn was mixed
with 0.71 mM human cTm and 5 mM actin filament in the presence of unlabeled- and IC3-labeled phalloidin to reconstitute the functional thin
filaments. Emission spectra were recorded at 25uC in F-buffer with the excitation wavelength of 490 nm and emission wavelengths from 500 nm to
750 nm. where: (A) Tn/Tm/F-actin/phalloidin/-Ca2+, (B) Tn/Tm/F-actin/phalloidin/+Ca2+, (C) Tn/Tm/F-actin/phalloidin/S1/-Ca2+, (D) Tn/Tm/F-actin/
phalloidin/S1/+Ca2+, (E) Tn/Tm/F-actin/IC3-phalloidin/-Ca2+, (F) Tn/Tm/F-actin/IC3-phalloidin/+Ca2+, (G) Tn/Tm/F-actin/IC3-phalloidin/S1/-Ca2+, (H) Tn/
Tm/F-actin/IC3-phalloidin/S1/+Ca2+.
doi:10.1371/journal.pone.0050420.g003
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orientation expected from the high anisotropy value, we used the
high resolution structure of TMR-G-actin [42] (PDB: 1J6Z) and a
published EM model of skeletal thin filament [43] to estimate the
angle h of the acceptor (TMR) probe on actin with regards to the
filament axis. As shown in Table 3, the difference in the
calculation of the Fo¨rster distance assuming the ideal dipole
approximation from that calculated from the model of the thin
filament is ,9% for residues 74 and 118 of sTnI, corresponding to
residues 107 and 151 in cTnI. The Pirani structure [43] is based
on the model of F-actin filament constructed by Holmes [44],
which is slightly different from the more recent model [45] in
terms of the orientation of the actin protomer. In spite of this
difference, according to the previous argument the error in the
distance calculation using the ideal dipole approximation cannot
exceed a value of 12%. Thus, in spite of the polarized emission of
the donor and acceptor probes in the thin filament preparations,
we are nonetheless justified in using the ideal dipole approxima-
tion i.e.vk2w of 2/3 in our calculations. The values of R0 for the
donor-acceptor probes used in this study are summarized in
Table 1.
The emission spectrum of fluorescein labeled cTnI (151C)
exhibited a maximum intensity at 515 nm in the absence of
acceptor. The intensity at this wavelength increased upon Ca2+/
S1 binding to the thin filament, as shown in figure 3. In the
presence of the acceptor (IC3-phalloidin), the fluorescence
intensity of the donor at 515 nm decreased with concomitant
appearance of a sensitized emission from the acceptor probe at
565 nm. The large degree of quenching of the donor emission at
515 nm made it possible to accurately determine the FRET
efficiency and to carry out determinations of the distance between
the donor and acceptor probes in the absence and presence of
calcium and myosin, using the equations described in Materials
and Methods and the R0 values calculated in Table 1. These
measurements and calculations were repeated for each of the 5
cTnI donor probes and acceptor sites on F-actin and cTm.
Conformational change of cTnI upon Ca2+/S1 binding to
the thin filaments
A matrix of the calculated FRET distances between the donor
and acceptor probes in the relaxed state of the thin filament are
shown in table 4, with the corresponding displacements of the
donor probes shown schematically in figure 4. In particular, the
binding of Ca2+ or S1 to the thin filament did not lead to any
significant displacement of residue 107 on cTnI with respect to
sites on F-actin. On the other hand, residues 151 and 188 of cTnI
displayed consistent behaviors, i.e., they both underwent signifi-
cant movements away from the outer domain of F-actin (Cysteine
374 of F-actin) by as much as 5 A˚ for cTnI151 and 13.6 A˚ for
cTnI188. In both cases these residues moved toward the
phalloidin binding site on the inner domain of the F-actin filament
(4 A˚ for cTnI151 and 1.9 A˚ for cTnI188). These two residues also
Table 4. Calculated distances between Donor labeled
troponin I single cysteine mutants and acceptor labeled on
actin/tropomyosin in the relaxed state (nm).
TnI107 TnI151 TnI188 TnI197 TnI210
Phalloidin 5.260.3 4.860.1 4.760.1 4.860.1 4.660.1
Tm190 5.6±0.2 5.260.1 5.160.2 5.160.2 4.960.2
Actin374 5.4±0.1 4.560.2 4.860.1 4.360.2 4.360.1
doi:10.1371/journal.pone.0050420.t004
Figure 4. Relative displacements of donor sites on cTnI to
acceptor sites within the thin filament upon Ca2+ and/or S1
binding. The distances were obtained by subtracting the distances
between donors and acceptors within the thin filament in the relaxed
state from that in the presence of Ca2+ and/or S1. Positive values
indicate that donors move away from acceptors and negative values
indicate that donors move towards acceptors. The color scheme is red
for the displacements of the donor on cTnI upon Ca2+-binding, green
for that upon S1-binding and blue for that upon both Ca2+ and S1-
binding. (A) Relative displacements of Fluorescein on sites of cTnI to IC3
on phalloidin. (B) Relative displacements of Fluorescein on sites of cTnI
to TMR on Cys190 on cTm. (C) Relative displacements of Fluorescein on
sites of cTnI to TMR on Cys374 on actin.
doi:10.1371/journal.pone.0050420.g004
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moved toward cysteine-190 on cTm (5 A˚ for cTnI151 and 3.6 A˚
for cTnI188). Residues 197 and 210 on cTnI moved away from all
three acceptor sites, although residue 210 did not move very far
from the Cysteine 190 of cTm. S1-binding did not induce any
further movement of these sites compared to their Ca2+-activated
loci. S1-binding alone however, resulted in similar movements to
Ca2+ for relaxed thin filaments.
Discussion
In a crystal structure of the 52 kD core domain of human
cardiac Tn [46], the N-terminal region of TnI (residues 42–136),
TnT (residues 203–271) and C-terminal domain of TnC constitute
an ‘‘IT arm’’, that anchors the complex at the C-terminus of Tm.
Residues 150–159 of TnI form an a-helix (a3) that interacts with
the N-terminal domain of TnC, whereas the adjacent a-helix (a4)
on TnI between residues 164–188 does not interact with other
components. These a-helices are linked to the IT arm by a flexible
region, which is unresolved in the Takeda structure [46] The
crystal structure of skeletal troponin [9] is similar to the cardiac
complex, although skeletal Tn differs at the C-terminus of TnI (as
shown in Figure 5A) [47]. In skTnI, the a4 helix is much shorter,
and is followed by a b-loop-b motif and two short a-helices (a5
and a6). This region, the so-called the ‘‘mobile domain’’, is highly
conserved and has several potential F-actin binding sites (as shown
in Figure 5A) [47]. The C-terminal region of cardiac TnI is also
required for full inhibition of the actomyosin ATPase [48].
Our study suggests that Ca2+ binding to TnC induces a
movement of the C-terminal domain of TnI but there did not
appear to be changes within regions of the IT arm (Figure 6).
Helices a3 (indicated by residue 151) and b-loop-b motif (indicated
by residue 188) move away from the outer domain of the actin
Figure 5. Schematic models of TnI. (A) structures of TnI. (i) Crystal structure of cTnI in the 52 kD core domain of cTn in the presence of Ca2+
(Takeda, et al., 2003; PDB 1J1E). Residues from 40 to 191 are resolved in this sturcture, and form four a-helices (a1, a2, a3 and a4). Helices a2 and a3
are linked by a flexible linker (residues 137–147) which is not resolved in the structure. (ii) Crystal structure of sTnI in the core domain of sTn in the
presence of Ca2+ (Vinogradova, et al., 2005; PDB 1YTZ). Residues from 3–143 are resolved in this structure, which is very similar to the structure of
cTnI. (iii) NMR stucture of C-terminus of sTnI [47] (PDB 1VDJ). Unlike the crystal structue of cTnI, the helix of a4 is much shorter, and was followed with
a b-loop-b motif and two short a-helices (a5 and a6). (iv), Alignment of the mobile domains from human cTnI and chicken fsTnI, which are highly
conserved. (B) Schematic structure of the calcium saturated thin filament. Helices a1 and a2 of cTnI interact with cTnT and form the ‘‘IT-arm’’, which
binds to the C-lobe of cTnC. N-lobe of cTnC interacts with cTnI helix a3 and the linker between a2 and a3. There are several potential actin binding
sites on C-terminus domain of TnI [47], as indicated by arrows. The color scheme is red for cTnI, green for cTnC, blue for cTnT and orange for actin
filament with cTm. (C) Point mutations that caused HCM (R145G/R145Q, R162W, K183D, S199N, G203S and K206Q) are showed in mengeta and the
donor labeling sites on cTnI used in this study (residues 107, 151,188, 197 and 210) are showed in blue.
doi:10.1371/journal.pone.0050420.g005
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filament and towards to the inner domain, while helices a5 and a6
(residue 197 and 210) move away from the filament. Previous
FRET studies on skeletal TnI also showed that the helix a4
(indicated by residue 133) moves away from outer domain of actin
filament upon Ca2+ binding, while helix a1 (indicated by residue 9)
only moves a short distance [21]. These results prompted the idea
that TnI behaves as a lever upon Ca2+ binding. In particular,
while the lever head (IT arm) is somewhat stationary, the lever
arm (a3, a4 and b-loop-b) undergoes an azimuthal movement
from the outer domain of F-actin towards the inner domain of the
filament. This movement induces a longitudinal movement of the
C-terminus region (a5 and a6) away from the actin filament. Our
study does not reveal any significant displacement between residue
210 on cTnI and the phalloidin binding site. This might due to the
special geometry between the donor and acceptor sites in our
system. Probes at position 107 of TnI, within the IT arm, were
relatively unresponsive to Ca2+ or S1 binding. Modification at this
position reduced the ability of troponin to inhibit the ATPase
activity in the absence of Ca2+ (Fig. 2). It is possible that distance
changes at this position were muted because the change in ATPase
activity was also reduced. However, the degree to which the FRET
changed was greater than the degree to which regulation differed
from the other labeling positions. The most likely explanation is
that the IT arm did not change or else that it changed in a
relatively small degree.
Studies on dysfunctional forms of cTnI associated with
hypertrophic cardiomyopathy (HCM) [15–17,19] reveal that some
of the disease-associated mutations localize to the C-terminus of
cTnI and include residues 145, 162, 183, 199, 203 and 206 (as
shown in figure 5C). These mutations alter the Ca2+-sensitivity of
the cardiac thin filament [16,17]. It is significant that our study
shows that this region undergoes a large Ca2+-induced movement
during activation of the thin filament.
In the steric-blocking and three-state models of thin filament
activation [49,50], Ca2+-binding is thought to induce a movement
of tropomyosin on the thin filament. Although structural studies
using X-ray diffraction and electron microscopy support this
hypothesis [49,51,52], the majority of FRET studies do not show
any evidence for such a movement [14,53–56]. Our present study
confirms this finding. According to our previous argument [14],
cTm experiences thermally-driven fluctuations in the blocked and
Ca2+-bound states of the thin filament that serve to decrease the
average distance between the donor probe on cTm and a fixed
acceptor probe on F-actin, to the point where FRET cannot
accurately detect a change in the loci on adding calcium or myosin
[14]. In the case of cTnI however, multi-site FRET analysis
reveals that Ca2+ binding to the thin filament triggers a significant
conformational transition for a specific domain of cTnI. This
movement is consistent with the suggestion that Ca2+-induced
azimuthal displacement of cTnI exposes a high affinity-binding
site on the filament for S1 binding (S1-ADP or nucleotide-free S1).
This conformational change may promote cooperative binding of
additional S1 molecules to the thin filament, an event that has
already been observed in the absence of ATP [57].
As we argued earlier [14], the binding of multiple S1 molecules
to the thin filament may simply push the cTm molecule away from
its locus in resting state on SD1 on F-actin and closer to sub-
domain 3 (SD1), defining the open-state of the thin filament. The
cooperative binding of S1 to the thin filament may also induce a
movement of the inhibitory region of the cTnI that could be
related to a slow kinetic process identified by Xing et al [28].
Finally, the cooperative binding of ATP-free S1 to the thin
filament is also known to be dependent on a site within the 14 C-
terminal residues of cTnT [58]. Deletion of these residues in cTnT
prevents full inactivation of the thin filament in the absence of
Ca2+ [59]. The relationship between changes in C-terminal TnT
binding and the location of the C-terminal region of TnI binding
shown here is unknown, although a multi-site FRET approach, as
employed here, could shed light on the structural and/or
functional significance of this observation.
Figure 6. A Schematic model of Ca2+-induced troponin I movement on the thin filament. The binding of Ca2+ and interaction of cTnI
triggers an opening of the N-lobe of cTnC, exposing a large hydrophobic site that increases the probability of interacting with cTnI. The negative free
energy associated with this change drives a conformational change in cTnI, and a movement of the C-terminus domain cTnI away from the outer
domain of actin filament. The color scheme is red for cTnI, green for cTnC, dark blue for cTnT and cyan for cTm. The actin filament is shown as
transparent surface. Cysteine 374 and phalloidin binding site are shown as red balls and the donor labeling sites on cTnI are shown as blue balls.
doi:10.1371/journal.pone.0050420.g006
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